Celiac disease (CD) comprises over 1% of the world's population and is a chronic
multisystem immune-mediated condition manifested by digestive and/or extradigestive …

Celiac disease (CD) is an autoimmune disorder caused by gluten intake in genetically
predisposed individuals. This article provides an overview of the available data on the risks …

The SARS-CoV-2 pandemic continues to pose a global threat. While its virulence has
subsided, it has persisted due to the continual emergence of new mutations. Although many …

The aim of this review is to broadly cover how the COVID-19 pandemic has affected
individuals with celiac disease, including perceived risk, risk of contraction or severe …

During the past 3 years, the coronavirus disease 2019 (COVID-19) pandemic has had a
great impact on people all over the world. However, it has become evident that disease …

There is a scarcity of scientific evidence addressing the outcomes of COVID‐19 in celiac
disease (CD) patients. This systematic review and meta‐analysis aimed to evaluate the …

Background: Globally, approximately 1.4% of people have celiac disease (CD), induced by
gluten sensitivity. If left untreated, it causes small intestinal inflammation and villous atrophy …

Background: Celiac disease (CD) is the most common multisystemic autoimmune disorder
affecting the pediatric population. However, little data is available regarding SARS-CoV-2 …

Background Celiac disease (CD) is an autoimmune disease affecting around 1.4% of the
total human population. Local and systemic manifestations are described in CD. Viral …

Background and aim: There is limited data on the prevalence of SARS-COV-2 in sarcoidosis
patients and the underlying parameters linked to severity. We aimed to conduct a national …